APO RESEARCH · REPORT
Hydroxychloroquine Sulphate
Hydroxychloroquine sulfate was listed in the United States in 1955 and used in malaria, rheumatoid arthritis and lupus erythematosus. The variety has been approved in more than 70 countries such as Canada, France, Germany, Australia, China, Japan, etc.
Product & engineering
Understand the product.
Hydroxychloroquine sulfate was listed in the United States in 1955 and used in malaria, rheumatoid arthritis and lupus erythematosus. The variety has been approved in more than 70 countries such as Canada, France, Germany, Australia, China, Japan, etc.
Hydroxychloroquine sulfate, initially an anti malarial drug, was found to have mild immunosuppressive and immunomodulatory effects in clinical practice.
Selected research
Industry Research
Hydroxychloroquine Sulphate Industry Research Report 2026
Market perspective
Hydroxychloroquine sulfate was listed in the United States in 1955 and used in malaria, rheumatoid arthritis and lupus erythematosus. The variety has been approved in more than 70 countries such as Canada, France, Germany, Australia, China, Japan, etc.
Hydroxychloroquine sulfate, initially an anti malarial drug, was found to have mild immunosuppressive and immunomodulatory effects in clinical practice.
The major producers in the industry are Sanofi, Novartis and Shanghai Zhongxisanwei, with their revenue ratios of 36.07%, 14.20% and 15.08% respectively in 2019.
Read the full market overview
Report Scope
This report quantifies the global Hydroxychloroquine Sulphate market in terms of revenue (US$ million) and, where applicable, sales volume (K Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hydroxychloroquine Sulphate Market by Company
Sanofi
Novartis
Shanghai Zhongxisanwei
Teva
Zydus Cadila
Mylan
Apotex
Advanz Pharma
Sun Pharma
Kyung Poong
Ipca Laboratories
Hanlim Pharmaceutical
Bristol Laboratories
Hydroxychloroquine Sulphate Segment by Type
100mg
200mg
Others
Hydroxychloroquine Sulphate Segment by Application
Lupus Erythematosus
Rheumatoid Arthritis
Others
Hydroxychloroquine Sulphate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxychloroquine Sulphate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydroxychloroquine Sulphate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxychloroquine Sulphate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hydroxychloroquine Sulphate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hydroxychloroquine Sulphate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hydroxychloroquine Sulphate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100mg
- 200mg
- Others
Applications
- Lupus Erythematosus
- Rheumatoid Arthritis
- Others
Companies covered
- Sanofi
- Novartis
- Shanghai Zhongxisanwei
- Teva
- Zydus Cadila
- Mylan
- Apotex
- Advanz Pharma
- Sun Pharma
- Kyung Poong
- Ipca Laboratories
- Hanlim Pharmaceutical
- Bristol Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hydroxychloroquine Sulphate Market Size (2021-2032)
- 2.2.2 Global Hydroxychloroquine Sulphate Sales (2021-2032)
- 2.2.3 Global Hydroxychloroquine Sulphate Market Average Price (2021-2032)
- 2.3 Hydroxychloroquine Sulphate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 100mg
- 2.3.3 200mg
- 2.3.4 Others
- 2.4 Hydroxychloroquine Sulphate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Lupus Erythematosus
- 2.4.3 Rheumatoid Arthritis
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hydroxychloroquine Sulphate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hydroxychloroquine Sulphate Sales (K Pcs) of Manufacturers (2021-2026)
- 3.3 Global Hydroxychloroquine Sulphate Revenue of Manufacturers (2021-2026)
- 3.4 Global Hydroxychloroquine Sulphate Average Price by Manufacturers (2021-2026)
- 3.5 Global Hydroxychloroquine Sulphate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hydroxychloroquine Sulphate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hydroxychloroquine Sulphate, Product Type & Application
- 3.8 Global Manufacturers of Hydroxychloroquine Sulphate, Established Date
- 3.9 Global Hydroxychloroquine Sulphate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Hydroxychloroquine Sulphate Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Hydroxychloroquine Sulphate Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Shanghai Zhongxisanwei
- 4.3.1 Shanghai Zhongxisanwei Company Information
- 4.3.2 Shanghai Zhongxisanwei Business Overview
- 4.3.3 Shanghai Zhongxisanwei Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shanghai Zhongxisanwei Hydroxychloroquine Sulphate Product Portfolio
- 4.3.5 Shanghai Zhongxisanwei Recent Developments
- 4.4 Teva
- 4.4.1 Teva Company Information
- 4.4.2 Teva Business Overview
- 4.4.3 Teva Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teva Hydroxychloroquine Sulphate Product Portfolio
- 4.4.5 Teva Recent Developments
- 4.5 Zydus Cadila
- 4.5.1 Zydus Cadila Company Information
- 4.5.2 Zydus Cadila Business Overview
- 4.5.3 Zydus Cadila Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zydus Cadila Hydroxychloroquine Sulphate Product Portfolio
- 4.5.5 Zydus Cadila Recent Developments
- 4.6 Mylan
- 4.6.1 Mylan Company Information
- 4.6.2 Mylan Business Overview
- 4.6.3 Mylan Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mylan Hydroxychloroquine Sulphate Product Portfolio
- 4.6.5 Mylan Recent Developments
- 4.7 Apotex
- 4.7.1 Apotex Company Information
- 4.7.2 Apotex Business Overview
- 4.7.3 Apotex Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Apotex Hydroxychloroquine Sulphate Product Portfolio
- 4.7.5 Apotex Recent Developments
- 4.8 Advanz Pharma
- 4.8.1 Advanz Pharma Company Information
- 4.8.2 Advanz Pharma Business Overview
- 4.8.3 Advanz Pharma Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Advanz Pharma Hydroxychloroquine Sulphate Product Portfolio
- 4.8.5 Advanz Pharma Recent Developments
- 4.9 Sun Pharma
- 4.9.1 Sun Pharma Company Information
- 4.9.2 Sun Pharma Business Overview
- 4.9.3 Sun Pharma Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sun Pharma Hydroxychloroquine Sulphate Product Portfolio
- 4.9.5 Sun Pharma Recent Developments
- 4.10 Kyung Poong
- 4.10.1 Kyung Poong Company Information
- 4.10.2 Kyung Poong Business Overview
- 4.10.3 Kyung Poong Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Kyung Poong Hydroxychloroquine Sulphate Product Portfolio
- 4.10.5 Kyung Poong Recent Developments
- 4.11 Ipca Laboratories
- 4.11.1 Ipca Laboratories Company Information
- 4.11.2 Ipca Laboratories Business Overview
- 4.11.3 Ipca Laboratories Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Ipca Laboratories Hydroxychloroquine Sulphate Product Portfolio
- 4.11.5 Ipca Laboratories Recent Developments
- 4.12 Hanlim Pharmaceutical
- 4.12.1 Hanlim Pharmaceutical Company Information
- 4.12.2 Hanlim Pharmaceutical Business Overview
- 4.12.3 Hanlim Pharmaceutical Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hanlim Pharmaceutical Hydroxychloroquine Sulphate Product Portfolio
- 4.12.5 Hanlim Pharmaceutical Recent Developments
- 4.13 Bristol Laboratories
- 4.13.1 Bristol Laboratories Company Information
- 4.13.2 Bristol Laboratories Business Overview
- 4.13.3 Bristol Laboratories Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Bristol Laboratories Hydroxychloroquine Sulphate Product Portfolio
- 4.13.5 Bristol Laboratories Recent Developments
5 Global Hydroxychloroquine Sulphate Market Scenario by Region
- 5.1 Global Hydroxychloroquine Sulphate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hydroxychloroquine Sulphate Sales by Region: 2021-2032
- 5.2.1 Global Hydroxychloroquine Sulphate Sales by Region: 2021-2026
- 5.2.2 Global Hydroxychloroquine Sulphate Sales by Region: 2027-2032
- 5.3 Global Hydroxychloroquine Sulphate Revenue by Region: 2021-2032
- 5.3.1 Global Hydroxychloroquine Sulphate Revenue by Region: 2021-2026
- 5.3.2 Global Hydroxychloroquine Sulphate Revenue by Region: 2027-2032
- 5.4 North America Hydroxychloroquine Sulphate Market Facts & Figures by Country
- 5.4.1 North America Hydroxychloroquine Sulphate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hydroxychloroquine Sulphate Sales by Country (2021-2032)
- 5.4.3 North America Hydroxychloroquine Sulphate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hydroxychloroquine Sulphate Market Facts & Figures by Country
- 5.5.1 Europe Hydroxychloroquine Sulphate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hydroxychloroquine Sulphate Sales by Country (2021-2032)
- 5.5.3 Europe Hydroxychloroquine Sulphate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hydroxychloroquine Sulphate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hydroxychloroquine Sulphate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hydroxychloroquine Sulphate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hydroxychloroquine Sulphate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hydroxychloroquine Sulphate Market Facts & Figures by Country
- 5.7.1 South America Hydroxychloroquine Sulphate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hydroxychloroquine Sulphate Sales by Country (2021-2032)
- 5.7.3 South America Hydroxychloroquine Sulphate Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Hydroxychloroquine Sulphate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hydroxychloroquine Sulphate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hydroxychloroquine Sulphate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hydroxychloroquine Sulphate Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hydroxychloroquine Sulphate Sales by Type (2021-2032)
- 6.1.1 Global Hydroxychloroquine Sulphate Sales by Type (2021-2032) & (K Pcs)
- 6.1.2 Global Hydroxychloroquine Sulphate Sales Market Share by Type (2021-2032)
- 6.2 Global Hydroxychloroquine Sulphate Revenue by Type (2021-2032)
- 6.2.1 Global Hydroxychloroquine Sulphate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hydroxychloroquine Sulphate Revenue Market Share by Type (2021-2032)
- 6.3 Global Hydroxychloroquine Sulphate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hydroxychloroquine Sulphate Sales by Application (2021-2032)
- 7.1.1 Global Hydroxychloroquine Sulphate Sales by Application (2021-2032) & (K Pcs)
- 7.1.2 Global Hydroxychloroquine Sulphate Sales Market Share by Application (2021-2032)
- 7.2 Global Hydroxychloroquine Sulphate Revenue by Application (2021-2032)
- 7.2.1 Global Hydroxychloroquine Sulphate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hydroxychloroquine Sulphate Revenue Market Share by Application (2021-2032)
- 7.3 Global Hydroxychloroquine Sulphate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hydroxychloroquine Sulphate Value Chain Analysis
- 8.1.1 Hydroxychloroquine Sulphate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hydroxychloroquine Sulphate Production Mode & Process
- 8.2 Hydroxychloroquine Sulphate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hydroxychloroquine Sulphate Distributors
- 8.2.3 Hydroxychloroquine Sulphate Customers
9 Global Hydroxychloroquine Sulphate Analyzing Market Dynamics
- 9.1 Hydroxychloroquine Sulphate Industry Trends
- 9.2 Hydroxychloroquine Sulphate Industry Drivers
- 9.3 Hydroxychloroquine Sulphate Industry Opportunities and Challenges
- 9.4 Hydroxychloroquine Sulphate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst